The management of the myelodysplastic child: a paradigm shift.
Bauer
S B
SB
Department of Urology, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Stuart.Bauer@tch.harvard.edu
D002648:Child; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009436:Neural Tube Defects / Q000150:complications / Q000628:therapy*; D011247:Pregnancy; D011295:Prenatal Care / Q000639:trends; D013566:Sympathomimetics / Q000627:therapeutic use; D016896:Treatment Outcome; D001743:Urinary Bladder / Q000601:surgery; D001750:Urinary Bladder, Neurogenic / Q000209:etiology / Q000601:surgery; D014546:Urinary Catheterization / Q000379:methods; D014547:Urinary Diversion; D014549:Urinary Incontinence / Q000209:etiology / Q000628:therapy*; D014718:Vesico-Ureteral Reflux / Q000209:etiology / Q000601:surgery
D018680:Cholinergic Antagonists; D013566:Sympathomimetics